Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures fell, with Dow futures down 450 points. Argenx sank 8.7% after a Sjögren’s trial was halted for futility; others also slid.
Stocks · News reference
UBS Maintains Buy on Dauch, Lowers Price Target to $8
UBS maintains Dauch (NYSE:DCH) with a Buy and lowers the price target from $9 to $8.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Jefferies Downgrades Dauch to Hold, Lowers Price Target to $7.1
Jefferies analyst Vanessa Jeffriess downgrades Dauch (NYSE:DCH) from Buy to Hold and lowers the price target from $8.25 to $7.1.
TD Cowen Upgrades Dauch to Buy, Raises Price Target to $10